Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Palonosetron, a 5-HT3 antagonist with Ki of 0.17 nM, is used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 349,000 |
50 mg | 約6-8 週間 | ¥ 454,500 |
100 mg | 約6-8 週間 | ¥ 574,000 |
説明 | Palonosetron, a 5-HT3 antagonist with Ki of 0.17 nM, is used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). |
ターゲット&IC50 | 5-HT3 receptor:0.17 nM(Ki) |
別名 | RS25259, RS 25259 197 |
分子量 | 296.41 |
分子式 | C19H24N2O |
CAS No. | 135729-61-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Palonosetron 135729-61-2 GPCR/G Protein Neuroscience 5-HT Receptor RS25259 RS 25259 RS-25259 RS 25259 197 Inhibitor inhibitor inhibit